Solventum Corporation (SOLV) Earnings Per Share (EPS): 8.17
Is Solventum Corporation’s earnings per share (EPS) high or low?
Solventum Corporation's earnings per share (EPS) of 8.17 is 16% above its 5-year average of 7.06, near the high end of its 5-year range (2.77–8.94).
As of Friday, June 12, 2026. 39.54% above its 12-month average of 5.85.
SOLV Earnings Per Share (EPS) Chart
SOLV Average Earnings Per Share (EPS) Chart
SOLV Current vs Average Earnings Per Share (EPS) Chart
SOLV Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
8.17
EARNINGS PER SHARE (EPS) AVG TTM
5.85
EARNINGS PER SHARE (EPS) AVG 3Y
6.82
EARNINGS PER SHARE (EPS) AVG 5Y
7.06
EARNINGS PER SHARE (EPS) AVG 10Y
7.06
EARNINGS PER SHARE (EPS) AVG 15Y
7.06
EARNINGS PER SHARE (EPS) AVG 20Y
7.06
CURRENT VS TTM AVG
+39.54%
CURRENT VS 3Y AVG
+19.74%
CURRENT VS 5Y AVG
+15.71%
CURRENT VS 10Y AVG
+15.71%
CURRENT VS 15Y AVG
+15.71%
CURRENT VS 20Y AVG
+15.71%
SOLV Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 8.17 | 5.85 | 6.82 | 7.06 |
| Align Technology, Inc. (ALGN) | $12.64B | 5.96 | 5.64 | 5.43 | 9.01 |
| Baxter International Inc. (BAX) | $10.70B | -2.10 | -1.51 | -0.65 | 0.36 |
| Hologic, Inc. (HOLX) | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | -3.76 | -1.35 | 4.03 | 5.21 |
| Tempus AI, Inc. (TEM) | $8.65B | -1.72 | -3.00 | -2.43 | -2.16 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 6.07 | -18.74 | -45.28 | 14.90 |
| Moderna, Inc. (MRNA) | $19.70B | -8.15 | -8.27 | -1.90 | 3.46 |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | -0.09 | 0.57 | 0.18 | -0.06 |
| BioNTech SE (BNTX) | $22.52B | -5.94 | -4.08 | 9.21 | 14.48 |
EPS Comparison
Trailing EPS (TTM)
$8.17
Forward EPS (Est.)
$7.06
P/E Ratio
9.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Solventum Corporation Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for Solventum Corporation (SOLV)?
- The earnings per share (EPS) for SOLV stock is 8.17.
- Is Solventum Corporation's earnings per share (EPS) high or low?
- Solventum Corporation's earnings per share (EPS) of 8.17 is 16% above its 5-year average of 7.06, near the high end of its 5-year range (2.77–8.94).
- What is the TTM average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The TTM average earnings per share (EPS) for SOLV stock is 5.85.
- What is the 3Y average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The 3Y average earnings per share (EPS) for SOLV stock is 6.82.
- What is the 5Y average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The 5Y average earnings per share (EPS) for SOLV stock is 7.06.
- What is the 10Y average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The 10Y average earnings per share (EPS) for SOLV stock is 7.06.
- What is the 15Y average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The 15Y average earnings per share (EPS) for SOLV stock is 7.06.
- What is the 20Y average earnings per share (EPS) for Solventum Corporation (SOLV)?
- The 20Y average earnings per share (EPS) for SOLV stock is 7.06.
Solventum Corporation Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 8.94 |
| 2024-12-31 | 2.77 |
| 2023-12-31 | 7.79 |
| 2022-12-31 | 7.79 |
| 2021-12-31 | 8.47 |
| 2020-12-31 | 6.60 |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson